Lori Volles

Title: Lori Volles: Innovator in Medical Treatment

Introduction

Lori Volles is a prominent inventor based in New Haven, CT (US). She has made significant contributions to the field of medicine, particularly in the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Her innovative approach has led to the development of a unique method for administering anti-C5 antibodies.

Latest Patents

Lori Volles holds a patent for the "Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)." This patent outlines methods for clinical treatment of PNH, which involve administering an anti-C5 antibody or its antigen-binding fragment subcutaneously. The treatment is designed according to a specific clinical dosage regimen, ensuring that patients receive the appropriate dose and schedule. Notably, this method is particularly beneficial for patients who have previously been treated with eculizumab (Soliris®).

Career Highlights

Lori Volles is associated with Alexion Pharmaceuticals, Inc., where she continues to advance her research and innovations in the medical field. Her work has been instrumental in improving treatment options for patients suffering from PNH.

Collaborations

Lori collaborates with esteemed colleagues, including Rajendra Pradhan and Douglas L. Sheridan. Their combined expertise contributes to the ongoing development of effective treatments in the pharmaceutical industry.

Conclusion

Lori Volles exemplifies the spirit of innovation in medicine through her groundbreaking patent and work at Alexion Pharmaceuticals, Inc. Her contributions are paving the way for improved patient care in the treatment of paroxysmal nocturnal hemoglobinuria.